Scarica l'app Stockscreener
1.73
0.57%
-0.01
Dopo l'orario di chiusura:
1.72
-0.01
-0.58%
Pepgen Inc Borsa (PEPG) Ultime notizie
PepGen crashes after mid-stage trial data for muscle disorder therapy - msn.com
PepGen stock plunges 26% on FDA partial clinical hold - Investing.com
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway - National Today
Wedbush Maintains PepGen (PEPG) Outperform Recommendation - msn.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - ChartMill
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com
PEPG Technical Analysis & Stock Price Forecast - Intellectia AI
Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
Assay what? Eyes on Pepgen’s vim-sapping DM1 phase II - BioWorld MedTech
Assay what? Eyes on Pepgen’s DM1 phase II - bioworld.com
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts - TipRanks
PEPG: FREEDOM2's 5 mg/kg cohort showed promising safety and efficacy, supporting dose escalation - TradingView
MACD Signal: What are the analyst revisions for NEOVIs PepGen Inc stock a good investment in YEAR2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
PepGen Shares Fall After Data From Ongoing Phase 2 Study for Myotonic Dystrophy Type 1 Patients - MarketScreener
PepGen's 5 mg/kg Data Outlier: Is This a Prelude to a 10 mg/kg Comeback or Evidence of a Failed Strategy? - Bitget
PepGen Plunges On Mixed Phase 2 Data, But Higher Dose Could Offer Some Relief - Seeking Alpha
PepGen’s Stock Plummets Amid FDA Trial Hold and Market Reaction - StocksToTrade
PepGen (NASDAQ:PEPG) Price Target Lowered to $5.00 at Wedbush - marketbeat.com
PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease - biospace.com
PepGen Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
A Quick Look at Today's Ratings for PepGen(PEPG.US), With a Forecast Between $3 to $20 - news.futunn.com
Why PEPG, SGMO, PHR are among top premarket losers today - MSN
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating - TipRanks
Wedbush Cuts Price Target on PepGen to $5 From $9, Keeps Outperform Rating - MarketScreener
Why Is PepGen Stock Sinking Tuesday?PepGen (NASDAQ:PEPG) - Benzinga
PepGen posts trial data for muscle disorder drug (PEPG:NASDAQ) - Seeking Alpha
PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT DataSlideshow (NASDAQ:PEPG) 2026-03-31 - Seeking Alpha
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data - BioSpace
PepGen reports ‘promising’ topline results from MAD cohort - TipRanks
PepGen stock tumbles 44% on disappointing trial results By Investing.com - Investing.com Canada
Movement Recap: Should I set a stop loss on PepGen Inc2026 Breakouts & Short-Term Trading Alerts - baoquankhu1.vn
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data - TipRanks
PepGen reports mixed results from DM1 trial, 10mg cohort ongoing By Investing.com - Investing.com Australia
PepGen reports favorable safety and splicing trends for 5 mg/kg cohort, on track for 10 mg/kg readout - TradingView
[8-K] PepGen Inc. Reports Material Event - Stock Titan
PepGen stock tumbles 44% on disappointing trial results - Investing.com
PepGen reports mixed results from DM1 trial, 10mg cohort ongoing - Investing.com
PepGen advances Phase 2 study with 10 mg/kg DM1 cohort under way - Traders Union
PepGen, Inc. (NASDAQ:PEPG) Short Interest Up 26.1% in March - MarketBeat
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD C - The National Law Review
S P Trends: Is PepGen Inc stock a smart retirement pick2026 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
PEPG Stock Price, Quote & Chart | PEPGEN INC (NASDAQ:PEPG) - ChartMill
Swing Trade: Why is PepGen Inc stock going downLong Setup & Daily Profit Maximizing Tips - baoquankhu1.vn
US FDA puts partial clinical hold on PepGen's muscle disease drug trial - MSN
If You Invested $1,000 in PepGen Inc (PEPG) - Stock Titan
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PEPG SEC FilingsPepGen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
COMMODORE CAPITAL LP Acquires Additional Shares in PepGen Inc - GuruFocus
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):